---
$id: https://graph.org.ai/products/commodity/51241117
$type: Product
source: UNSPSC
code: "51241117"
title: "Unoprostone"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Unoprostone

**UNSPSC Code**: 51241117
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue and anti-glaucoma agent with the molecular formula C22H38O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X4F561V3W, chemically known as 13,14-dihydro-15-keto-20-ethyl pgf2alpha but generally known as unoprostone, which bears US NIH Compound Identifier 5311236. European Medicines Agency schedules Unoprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11381MIG. The term UNOPROSTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules unoprostone in its Anatomical Therapeutic Chemical (ATC) Classification. UNOPROSTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule unoprostone under HS 29375000 and SITC 54156. As of Q4 2014, UNOPROSTONE remains the US FDA Preferred Term for this commodity. Unoprostone bears US NLM identifiers UMLS ID C0772319 and NCI Concept Code C76904. SMILES: OC1C(C(C(O)C1)C/C=C\CCCC(=O)O)CCC(=O)CCCCCCC.

